More 2021 predictions: Drug pricing, X modifiers, HHS chief

Why This Topic Matters

It helps readers understand which policy and regulatory issues could shape reimbursement, compliance, and administrative planning in the coming year.

Article Sections

1. Predictions 2021 continued

   An overview of the main health policy predictions discussed in the article, including drug pricing, CMS guidance, federal leadership, and ACA litigation.

2. Drug pricing policy and the international pricing index

   Discussion of anticipated changes to federal drug pricing policy, the status of an existing pricing rule, and the broader policy debate around Medicare drug reimbursement.

3. X modifiers

   Coverage of CMS’s X modifier series and expectations for future guidance or broader adoption in medical coding and reporting.

4. HHS chief

   Analysis of the expected HHS Secretary nomination process and political factors that could affect confirmation.

5. The Supreme Court and Obamacare

   Discussion of the pending Supreme Court ACA case and expectations about its implications for the Affordable Care Act.